LYVISPAH 10 MG GRANULE PACKET

baclofen
$3.4541per EA
High Outlier

Strength

10 mg/1

NDC

64896007709

Classification

Brand

Dosage Form

GRANULE

Route

ORAL

Last Updated

3/19/2025

Active Ingredients

BACLOFEN

Approval Type

New Drug (NDA)

FDA Application

NDA215422

On Market Since

6/1/2023

Pharmacological Classes

GABA A Agonists
GABA B Agonists
gamma-Aminobutyric Acid-ergic Agonist

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

N/A

5Y

N/A

All

N/A

Related Drugs

Same classification

No related drugs found.